These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 18284933)

  • 1. Aurora kinase expression in colorectal adenocarcinoma: correlations with clinicopathological features, p16 expression, and telomerase activity.
    Lam AK; Ong K; Ho YH
    Hum Pathol; 2008 Apr; 39(4):599-604. PubMed ID: 18284933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced p16 expression correlates with lymphatic invasion in colorectal cancers.
    Tada T; Watanabe T; Kazama S; Kanazawa T; Hata K; Komuro Y; Nagawa H
    Hepatogastroenterology; 2003; 50(54):1756-60. PubMed ID: 14696398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of pRB, p16 and cyclin D1 in colonic carcinogenesis.
    Ayhan S; Isisag A; Saruc M; Nese N; Demir MA; Kucukmetin NT
    Hepatogastroenterology; 2010; 57(98):251-6. PubMed ID: 20583423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p16 expression in colorectal adenocarcinoma: marker of aggressiveness and morphological types.
    Lam AK; Ong K; Giv MJ; Ho YH
    Pathology; 2008 Oct; 40(6):580-5. PubMed ID: 18752124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative analysis of survivin in colorectal adenocarcinoma: increased expression and correlation with telomerase activity.
    Lam AK; Saleh S; Smith RA; Ho YH
    Hum Pathol; 2008 Aug; 39(8):1229-33. PubMed ID: 18547619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinicopathological significance of expressions of DNA dependent protein kinase catalytic subunit and P16 in colorectal carcinoma].
    Lü Y; Zhang HL; Li YZ; Zhao P
    Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(29):2025-9. PubMed ID: 19080428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of methylated p15 and p16 genes on clinicopathological features in colorectal cancer.
    Ishiguro A; Takahata T; Saito M; Yoshiya G; Tamura Y; Sasaki M; Munakata A
    J Gastroenterol Hepatol; 2006 Aug; 21(8):1334-9. PubMed ID: 16872319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human telomerase reverse transcriptase expression in colorectal tumors: correlations with immunohistochemical expression and clinicopathologic features.
    Simsek BC; Pehlivan S; Karaoglu A
    Ann Diagn Pathol; 2010 Dec; 14(6):413-7. PubMed ID: 21074689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Copy number increase of aurora kinase A in colorectal cancers: a correlation with tumor progression.
    Zhang C; Fang Z; Xiong Y; Li J; Liu L; Li M; Zhang W; Wan J
    Acta Biochim Biophys Sin (Shanghai); 2010 Nov; 42(11):834-8. PubMed ID: 20929925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EphB1 is underexpressed in poorly differentiated colorectal cancers.
    Sheng Z; Wang J; Dong Y; Ma H; Zhou H; Sugimura H; Lu G; Zhou X
    Pathobiology; 2008; 75(5):274-80. PubMed ID: 18931529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Semi-quantitative procedure for telomeric repeat amplification protocol (TRAP) assay in colorectal carcinomas.
    Fujita M; Tomita S; Fukui H; Ueda Y; Fujimori T
    J Exp Clin Cancer Res; 1999 Mar; 18(1):119-24. PubMed ID: 10374691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of p16 in lymph node metastases of adjuvantly treated stage III colorectal cancer patients identifies poor prognostic subgroups: a retrospective analysis of biomarkers in matched primary tumor and lymph node metastases.
    Karamitopoulou E; Zlobec I; Koumarianou A; Patsouris ES; Peros G; Lugli A
    Cancer; 2010 Oct; 116(19):4474-86. PubMed ID: 20572035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of serine threonine kinase 15 is associated with poor differentiation in lung squamous cell carcinoma and adenocarcinoma.
    Xu HT; Ma L; Qi FJ; Liu Y; Yu JH; Dai SD; Zhu JJ; Wang EH
    Pathol Int; 2006 Jul; 56(7):375-80. PubMed ID: 16792546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of alpha-methylacyl-coenzyme A racemase in colorectal carcinoma bears clinical and pathologic significance.
    Lin A; Weiser MR; Klimstra DS; Paty PB; Tang LH; Al-Ahmadie H; Hoo Park S; Guillem JG; Temple L; Wong WD; Gerald WL; Shia J
    Hum Pathol; 2007 Jun; 38(6):850-6. PubMed ID: 17442371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telomerase activity and hTERT mRNA in development and progression of adenoma to colorectal cancer.
    Kanamaru T; Tanaka K; Kotani J; Ueno K; Yamamoto M; Idei Y; Hisatomi H; Takeyama Y
    Int J Mol Med; 2002 Aug; 10(2):205-10. PubMed ID: 12119560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p16(INK4a) promoter methylation and 9p21 allelic loss in colorectal carcinomas: relation with immunohistochemical p16(INK4a) expression and with tumor budding.
    Prall F; Ostwald C; Weirich V; Nizze H
    Hum Pathol; 2006 May; 37(5):578-85. PubMed ID: 16647956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Papillomavirus type 16 E6/E7 and human telomerase reverse transcriptase in esophageal cell immortalization and early transformation.
    Zhang H; Jin Y; Chen X; Jin C; Law S; Tsao SW; Kwong YL
    Cancer Lett; 2007 Jan; 245(1-2):184-94. PubMed ID: 16488074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telomerase activity of blood samples and recurrence of colorectal cancer.
    Ohnishi T; Watanabe T; Nozawa H; Kitayama J; Nagawa H
    Hepatogastroenterology; 2008; 55(86-87):1513-8. PubMed ID: 19102333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telomerase activity in stage II colorectal carcinoma.
    Kawanishi-Tabata R; Lopez F; Fratantonio S; Kim N; Goldblum J; Tubbs R; Elson P; Lavery I; Bukowski RM; Ganapathi R; Ganapathi MK
    Cancer; 2002 Nov; 95(9):1834-9. PubMed ID: 12404275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormalities in the expression of cell cycle-related proteins in tumors of the small bowel.
    Arber N; Hibshoosh H; Yasui W; Neugut AI; Hibshoosh A; Yao Y; Sgambato A; Yamamoto H; Shapira I; Rosenman D; Fabian I; Weinstein IB; Tahara E; Holt PR
    Cancer Epidemiol Biomarkers Prev; 1999 Dec; 8(12):1101-5. PubMed ID: 10613343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.